Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Petros Pharmaceuticals's price to sales ratio was 0.0× on Apr 30, 2025, against 1.3× a year earlier. Over the last 3 years it ranged from 0.0× to 4.1×, with a median of 1.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 0.0× | −0.3 |
| 2024 | Jan 31, 2024 | 0.4× | −0.1 |
| 2023 | Dec 29, 2023 | 0.4× | −0.2 |
| 2022 | Dec 30, 2022 | 0.6× | −1.9 |
| 2021 | Dec 31, 2021 | 2.5× | – |
See a number that looks wrong?